MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Gait Analysis in Parkinson’s Disease with Mixed Reality

    M. Wójcik-Pędziwiatr, D. Hemmerling, J. Stępień, M. Yufan, M. Kaczmarska, W. Szecówka, A. Srinivasa, M. Rudzińska-Bar (Cracow, Poland)

    Objective: This study aims to analyze gait differences between individuals with Parkinson’s disease (PD) and healthy participants using the Timed Up-and-Go (TUG) test, exploring the…
  • 2025 International Congress

    AI-Driven Prediction Models for Advanced Parkinson’s Disease: A Data-Driven Approach Using PPMI and CDEPA Criteria

    I. Gabilondo, A. Saenz, S. Seijo, A. Ochoa, U. Zalabarria, I. Cuenca, B. Tijero, T. Fernandez, M. Ruiz, M. Acera, J. Gomez, R. Del Pino (Barakaldo, Spain)

    Objective: To develop machine learning models that predict advanced Parkinson’s disease (APD) by integrating quantitative clinical data from the Parkinson’s Progression Markers Initiative (PPMI) with…
  • 2025 International Congress

    Boosting Education and Awareness Together for people with Parkinson’s Disease (BEATs-PD): Methodological Considerations in Research Co-Creation

    R. Khamishon, K. Devlin, B. Advisory Board, K. Kang, L. Currens, E. Lu, S. Phelan, E. Choi, S. Willoughby, A. Pantelyat, K. Mills (Baltimore, USA)

    Objective: To describe methodological considerations related to stakeholder engagement in community-based participatory research (CBPR) to create a dance and music-based program (DMBP) for people with…
  • 2025 International Congress

    Audit Of A Multidisciplinary Day Hospital For Parkinson’s and Falls (2019–2024)

    J. Ponce, C. Krishnan, A. Withanage, K. Fairhurst (New Lambton Heights, Australia)

    Objective: To assess a multidisciplinary hospital day service for Parkinson’s disease and fall-related concerns, identify service gaps, and evaluate its 5-year impact. Background: The Day…
  • 2025 International Congress

    Automating the assessment of motor symptoms of Parkinson’s: exploring the scope of assessment possible in a video-based approach.

    A. Podlewska, R. Singh, M. Squires, B. Bridges (London, United Kingdom)

    Objective: To explore the scope of the PRIMS assessment in People with Parkinson’s (PwP), including symptom severity rating, assessment time, individual assessment item completion and…
  • 2025 International Congress

    Improving Guitar Strumming Mechanics in Parkinson’s Disease: A Case Series Using a Forearm Stabilization Device

    J. Lenger, S. Matsushita, T. Lesiuk, M. Kerulis, N. Punjabi (Miami, USA)

    Objective: This case series aims to explore the potential benefits of a guitar adaptation in enhancing mechanics of guitar strumming among this patient sample. Specifically,…
  • 2025 International Congress

    Spectrum of Movement Disorders Associated With Autoimmune Thyroid Disease

    A. Maheshwary, S. Anderson, N. Prakash (Farmington, USA)

    Objective: To describe the spectrum of movement disorders in patients with positive anti-thyroid antibodies (ATA+). Background: Autoimmune thyroid diseases (AITD), including Hashimoto’s thyroiditis (HT) and…
  • 2025 International Congress

    Contribution of β-band functional connectivity to the α-synuclein propagation in early-stage Parkinson’s Disease: insights from the analysis of brain network properties

    M. Conti, A. Guerra, V. Ferrari, V. D'Onofrio, G. Sancesario, M. Pierantozzi, NB. Mercuri, A. Antonini, T. Schirinzi, A. Stefani (Rome, Italy)

    Objective: To investigate the relationship between CSF α-synuclein levels and EEG-based network properties, aiming to clarify their role in PD pathophysiology. Background: Parkinson’s disease (PD)…
  • 2025 International Congress

    Rare Phenomenology with Nicotinic Ganglionic Acetylcholine Receptor Antibodies

    V. Melnic, J. Frey (Morgantown, USA)

    Objective: Autoimmune dysautonomia has been described in patients with positive nicotinic ganglionic (alpha-3) acetylcholine receptor antibodies (α3-AchR Ab). We present a case of myoclonus in…
  • 2025 International Congress

    Neuroprotective Role of Diosgenin-Loaded Lipid Nanoparticles for Parkinson’s Disease: Pharmacokinetic and Pharmacodynamic Insights

    R. Rajput, S. Verma (Agra, India)

    Objective: To develop, optimize, and evaluate diosgenin-loaded solid lipid nanoparticles (DG-SLNs) and nanostructured lipid carriers (DG-NLCs) incorporated into hydrogel formulations (DG-SLN-C and DG-NLC-C) for improved…
  • « Previous Page
  • 1
  • …
  • 257
  • 258
  • 259
  • 260
  • 261
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley